COST-UTILITY ANALYSIS AND EFFICIENCY FRONTIER APPROACH OF TAFASITAMAB IN BRAZILIAN PRIVATE HEALTHCARE SYSTEM PERSPECTIVE

被引：0
|
作者：
Fahham, L. [1 ]
Dias, L. [2 ]
Amaral, L. Murta [2 ]
Mazzuco, C. [3 ]
Araujo, G. [3 ]
机构：
[1] ORIGIN Hlth, Sao Paulo, Brazil
[2] ORIGIN Hlth, Rio De Janeiro, RJ, Brazil
[3] Knight Therapeut, Sao Paulo, SP, Brazil
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE442
引用
收藏
页数：2
相关论文
共 50 条
  • [31] COST-UTILITY ANALYSIS OF MEPOLIZUMAB VERSUS BENRALIZUMAB FOR SEVERE EOSINOPHILIC ASTHMA IN THE COLOMBIAN HEALTHCARE SYSTEM
    Rodriguez, E.
    Garcia Nuncira, C. Y.
    VALUE IN HEALTH, 2020, 23 : S350 - S350
  • [32] COST-UTILITY ANALYSIS OF TALAZOPARIB VERSUS CHEMOTHERAPY FOR PATIENTS WITH BREAST CANCER HER2-WITH MUTATION IN THE BRCA1/2 GENE FROM THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
    Almeida, P.
    Sebastiao, M.
    Ferreira, P.
    Senna, T.
    Alexandre, R. F.
    VALUE IN HEALTH, 2023, 26 (06) : S274 - S274
  • [33] COST MINIMIZATION ANALYSIS IN THE SWITCH OF INFLIXIMAB FOR ITS BIOSIMILAR IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
    Alexandre, R. F.
    Squiassi, H. B.
    Santana, C. F.
    VALUE IN HEALTH, 2017, 20 (05) : A147 - A147
  • [34] Discounting in cost-utility analysis of healthcare interventions - Reassessing current practice
    Cohen, BJ
    PHARMACOECONOMICS, 2003, 21 (02) : 75 - 87
  • [35] A COST-UTILITY ANALYSIS OF ARTIFICIAL URINARY SPHINCTER VERSUS BSC IN SEVERE MALE POSTPROSTATECTOMY INCONTINENCE - BRAZILIAN PUBLIC HEALTH SYSTEM PERSPECTIVE
    Tortele, H.
    Rodrigues, S.
    Conto, M.
    VALUE IN HEALTH, 2023, 26 (06) : S298 - S298
  • [36] COST-EFFECTIVENESS OF THE INITIAL TREATMENT OF VENOUS THROMBOEMBOLISM FROM THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM PERSPECTIVE
    Alexandre, R. F.
    Squiassi, H. B.
    Santana, C. F.
    Nascimento, R.
    Lucchetta, R.
    Riveros, B. S.
    Pedro, G. O.
    Nita, M. E.
    VALUE IN HEALTH, 2017, 20 (05) : A29 - A29
  • [37] OPEN VERSUS LAPAROSCOPIC PROCEDURES FOR CHOLECYSTECTOMY SURGERY: A COST-UTILITY ANALYSIS, UNDER THE BRAZILIAN PUBLIC PAYER PERSPECTIVE
    Nasciben, V
    Saggia, M. G.
    Sanchez, J. F.
    VALUE IN HEALTH, 2010, 13 (03) : A73 - A73
  • [38] Cost-utility of reduction mammaplasty in the Brazilian National Public Health Care System
    Araujo, Carlos Delano
    Veiga, Daniela Francescato
    Oliveira, Ana Carolina
    Hochman, Bernardo
    Abla, Luiz Eduardo
    Veiga-Filho, Joel
    Novo, Neil Ferreira
    Ferreira, Lydia Masako
    JOURNAL OF WOMENS HEALTH, 2012, 21 (04) : 32 - 32
  • [39] Cost-utility analysis of pembrolizumab versus nivolumab in the treatment of metastatic colorectal cancer from the perspective of the healthcare payer
    Lu, Zhen
    Huang, Xiaoyan
    Ou, Yingjuan
    Wang, Qinbo
    Tan, Qirong
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2025,
  • [40] Diagnostic Approach in Fetal Coarctation of the Aorta: A Cost-Utility Analysis
    Evers, Patrick D.
    Ranade, Daksha
    Lewin, Mark
    Arya, Bhawna
    JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2017, 30 (06) : 589 - 594
12345